Reuters logo
BRIEF-Astrazeneca says U.S. FDA approves once-daily qtern for type-2 diabetes
February 28, 2017 / 7:55 AM / 7 months ago

BRIEF-Astrazeneca says U.S. FDA approves once-daily qtern for type-2 diabetes

Feb 28 (Reuters) - Astrazeneca Plc

* FDA approves once-daily qtern for type-2 diabetes

* Astrazeneca - qtern fixed-dose combination will provide additional oral medicine option for patients taking farxiga to improve blood sugar level (Bengaluru Newsroom: +91 80 6749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below